CERSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

CERUS CORP

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026

$2.22+0.04 (+1.83%)

Close on Oct 19, 2026

Market cap: $445.25M
P/E (TTM): –
Dividend yield: –

Dividends

Cerus has not reported a dividend

No dividend per share appears in Cerus's annual filings since fiscal 2010.

Where these numbers come from

Parsed from the XBRL in Cerus's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is CERS.

Revenue growth16.1% · median 11.8%

Operating margin-0.7% · median 2.5%

Net margin-2.9% · median 1.8%

Company	Revenue	Growth
PEN	$1.50B	+17.6%
MDXG	$355.17M	-2.4%
PRCT	$337.34M	+22.7%
LMAT	$262.43M	+11.8%
CERS	$233.80M	+16.1%
CTSO	$37.22M	+3.1%

Company

Next earnings (est.): Nov 5, 2026, during market hours
Exchange: Nasdaq
Industry: Surgical & Medical Instruments & Apparatus
Fiscal year ends: December 31
Employees: 275
Held by institutions: 74.8%
Auditor: Ernst & Young LLP
SEC CIK: 1020214

Advertisement
300 × 250